| Announce Date | 11/12/2025 |
| EPS Normalized Actual | $-1.18 (Beat by $0.12) |
| EPS GAAP Actual | $-1.18 (Beat by $0.12) |
| Revenue Actual | $0.002658B |
| Revenue Surprise | Beat by $2.658M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.83 |
| EPS GAAP Estimate | $-0.83 |
| Revenue Estimate | $0.0055B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0.23 | 4.78 | 0.22769 | 0.23231 | 0 |
| Dec 2027 | 0.05 | 22 | 0.04949703 | 0.05050297 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -1.53 | -1.41 | 0.002658B | -101.92% | -17.94M |
| FQ2 2025 (Jun 2025) | -1.28 | -1.15 | 0.003379B | -248.21% | -15.62M |
| FQ4 2020 (Dec 2020) | -0.0012 | -0.0012 | 0B | NAN% | 0M |
| FQ1 2025 (Mar 2025) | 1.54 | 1.73 | 0.00558B | -68.21% | -11.52M |
| FQ4 2024 (Dec 2024) | -0.0079 | 0.1321 | 0.005591B | 100% | -12.31M |
| FQ3 2024 (Sep 2024) | -0.14 | 0.1 | 0.005367B | 100% | -5.53M |
| FQ2 2024 (Jun 2024) | -0.0451 | 0.1749 | 0.011766B | 100% | -2.23M |
| FQ1 2021 (Mar 2021) | -0.0481 | -0.0481 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.83
Consensus Revenue Estimates
0.0055B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.88 | -- | -1.04888 | -0.71112 | 1 |
| FQ3 2026 (Sep 2026) | -0.45 | -240 | -0.53492 | -0.41226 | 1 |
| FQ2 2026 (Jun 2026) | -0.42 | -204.76 | -0.49926 | -0.38477 | 1 |
| FQ1 2026 (Mar 2026) | -0.83 | 285.54 | -0.98928 | -0.67072 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ3 2026 (Sep 2026) | 0.01B | 80.74 | 0.01B | 0.02B | 2 |
| FQ2 2026 (Jun 2026) | 0.01B | 73.6 | 0.01B | 0.01B | 2 |
| FQ1 2026 (Mar 2026) | 0.01B | -1.45 | 0B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
0
Revenue # of Misses
6
Revenue # of in-lines
2
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.12 | -1.53 | -1.41 | 92.16% |
| FQ2 2025 (Jun 2025) | -0.13 | -1.28 | -1.15 | 89.84% |
| FQ4 2020 (Dec 2020) | -0.0012 | -0.0012 | 100% | |
| FQ1 2025 (Mar 2025) | -0.19 | 1.54 | 1.73 | 112.34% |
| FQ4 2024 (Dec 2024) | -0.14 | -0.0079 | 0.1321 | -1672.15% |
| FQ3 2024 (Sep 2024) | -0.24 | -0.14 | 0.1 | -71.43% |
| FQ2 2024 (Jun 2024) | -0.22 | -0.0451 | 0.1749 | -387.8% |
| FQ1 2021 (Mar 2021) | -0.0481 | -0.0481 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.02B | $0B | $-17.94M | -675.02% |
| FQ2 2025 (Jun 2025) | $0.02B | $0B | $-15.62M | -462.3% |
| FQ4 2020 (Dec 2020) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Mar 2025) | $0.02B | $0.01B | $-11.52M | -206.45% |
| FQ4 2024 (Dec 2024) | $0.02B | $0.01B | $-12.31M | -220.16% |
| FQ3 2024 (Sep 2024) | $0.01B | $0.01B | $-5.53M | -103.09% |
| FQ2 2024 (Jun 2024) | $0.01B | $0.01B | $-2.23M | -18.99% |
| FQ1 2021 (Mar 2021) | $0B | $0B | $0M | NAN% |